{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:40:52Z","timestamp":1791330052194,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03587-7","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:58:10Z","timestamp":1736330290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["HCV and HBV genotypes: vital in the progression of HCV\/ HBV co-infection"],"prefix":"10.1186","volume":"25","author":[{"given":"Yasmin","family":"Badshah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Shabbir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbukhat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameen","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyaba","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fohad Mabood","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail","family":"Razak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"13","key":"3587_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.12998\/wjcc.v6.i13.589","volume":"6","author":"M Jefferies","year":"2018","unstructured":"Jefferies M, et al. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases. 2018;6(13):589.","journal-title":"World J Clin Cases"},{"issue":"1","key":"3587_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10620-022-07484-x","volume":"68","author":"E Jones","year":"2023","unstructured":"Jones E, et al. Overlooked symptoms in autoimmune hepatitis negatively impact many facets of life. Dig Dis Sci. 2023;68(1):77\u201386.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"3587_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","volume":"8","author":"F Cui","year":"2023","unstructured":"Cui F, et al. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Lancet Gastroenterol Hepatol. 2023;8(4):332\u201342.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"3587_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/vim.2019.0058","volume":"32","author":"A Haqqi","year":"2019","unstructured":"Haqqi A, et al. Prevalence of hepatitis C virus genotypes in Pakistan: current scenario and review of literature. Viral Immunol. 2019;32(9):402\u201313.","journal-title":"Viral Immunol"},{"key":"3587_CR5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10389-019-01081-5","volume":"28","author":"S Mehmood","year":"2020","unstructured":"Mehmood S, et al. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. J Public Health. 2020;28:751\u201364.","journal-title":"J Public Health"},{"issue":"5","key":"3587_CR6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/2050640619840149","volume":"7","author":"S Ekpanyapong","year":"2019","unstructured":"Ekpanyapong S, Reddy KR. Hepatitis C virus therapy in advanced liver disease: outcomes and challenges. United Eur Gastroenterol J. 2019;7(5):642\u201350.","journal-title":"United Eur Gastroenterol J"},{"issue":"2","key":"3587_CR7","doi-asserted-by":"publisher","first-page":"e0228847","DOI":"10.1371\/journal.pone.0228847","volume":"15","author":"SV Patel","year":"2020","unstructured":"Patel SV, et al. Real-world efficacy of direct acting antiviral therapies in patients with HIV\/HCV. PLoS ONE. 2020;15(2):e0228847.","journal-title":"PLoS ONE"},{"issue":"7","key":"3587_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/v12070741","volume":"12","author":"Y-F Shih","year":"2020","unstructured":"Shih Y-F, Liu C-J. Hepatitis C virus and hepatitis B virus co-infection. Viruses. 2020;12(7):741.","journal-title":"Viruses"},{"issue":"1","key":"3587_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1743-422X-8-102","volume":"8","author":"M Ali","year":"2011","unstructured":"Ali M, et al. Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J. 2011;8(1):102.","journal-title":"Virol J"},{"key":"3587_CR10","doi-asserted-by":"crossref","unstructured":"Osman HA et al. Management of patients with hepatitis B virus reactivation post\u2013DAA treatment of chronic hepatitis C virus infection in HCV\u2013HBV coinfected patients with pretreatment HBeAg seroconversion and early degree of hepatic fibrosis. Infect Drug Resist, 2019: pp. 3067\u201373.","DOI":"10.2147\/IDR.S215974"},{"issue":"3","key":"3587_CR11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/cid\/ciz1097","volume":"71","author":"AA Butt","year":"2020","unstructured":"Butt AA, et al. Liver fibrosis progression and mortality in hepatitis B\u2013and C\u2013coinfected persons treated with directly acting antiviral agents: results from ERCHIVES. Clin Infect Dis. 2020;71(3):664\u20136.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3587_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12985-021-01580-6","volume":"18","author":"R Xu","year":"2021","unstructured":"Xu R, et al. Advances in HBV infection and replication systems in vitro. Virol J. 2021;18(1):105.","journal-title":"Virol J"},{"issue":"16","key":"3587_CR13","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.3390\/ijms21165677","volume":"21","author":"RD Kunden","year":"2020","unstructured":"Kunden RD, et al. The role of the liver-specific microRNA, miRNA-122 in the HCV replication cycle. Int J Mol Sci. 2020;21(16):5677.","journal-title":"Int J Mol Sci"},{"key":"3587_CR14","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.3389\/fimmu.2019.03079","volume":"10","author":"R Mishra","year":"2020","unstructured":"Mishra R, et al. The interplay between viral-derived miRNAs and host immunity during infection. Front Immunol. 2020;10:3079.","journal-title":"Front Immunol"},{"issue":"11","key":"3587_CR15","doi-asserted-by":"publisher","first-page":"e1008593","DOI":"10.1371\/journal.ppat.1008593","volume":"16","author":"H Chabrolles","year":"2020","unstructured":"Chabrolles H, et al. Hepatitis B virus core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production. PLoS Pathog. 2020;16(11):e1008593.","journal-title":"PLoS Pathog"},{"issue":"12","key":"3587_CR16","doi-asserted-by":"publisher","first-page":"001701","DOI":"10.1099\/jgv.0.001701","volume":"102","author":"S Lee","year":"2021","unstructured":"Lee S, et al. Hepatitis C virus core protein inhibits hepatitis B virus replication by downregulating HBx levels via Siah-1-mediated proteasomal degradation during coinfection. J Gen Virol. 2021;102(12):001701.","journal-title":"J Gen Virol"},{"issue":"1","key":"3587_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41598-020-57603-9","volume":"10","author":"K Murai","year":"2020","unstructured":"Murai K, et al. Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway. Sci Rep. 2020;10(1):941.","journal-title":"Sci Rep"},{"issue":"3","key":"3587_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.14218\/JCTH.2018.00016","volume":"6","author":"MG Mavilia","year":"2018","unstructured":"Mavilia MG, Wu GY. Coinfection: viral interactions, management, and viral reactivation. J Clin Transl Hepatol. 2018;6(3):296\u2013305.","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"3587_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/j.gastro.2018.02.005","volume":"154","author":"AT Ma","year":"2018","unstructured":"Ma AT, Feld JJ. Hepatitis B Reactivation with Hepatitis C treatment: bringing some clarity to the Black Box. Gastroenterology. 2018;154(4):795\u20138.","journal-title":"Gastroenterology"},{"issue":"2","key":"3587_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.gtc.2020.01.001","volume":"49","author":"H Razavi","year":"2020","unstructured":"Razavi H. Global epidemiology of viral hepatitis. Gastroenterol Clin. 2020;49(2):179\u201389.","journal-title":"Gastroenterol Clin"},{"issue":"4","key":"3587_CR21","doi-asserted-by":"publisher","first-page":"135965352311896","DOI":"10.1177\/13596535231189643","volume":"28","author":"Q Maqsood","year":"2023","unstructured":"Maqsood Q, et al. Hepatitis C virus\/Hepatitis B virus coinfection: current prospectives. Antivir Ther. 2023;28(4):13596535231189643.","journal-title":"Antivir Ther"},{"issue":"2","key":"3587_CR22","first-page":"221","volume":"28","author":"D Konstantinou","year":"2015","unstructured":"Konstantinou D, Deutsch M. The spectrum of HBV\/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol. 2015;28(2):221\u20138.","journal-title":"Ann Gastroenterol"},{"key":"3587_CR23","doi-asserted-by":"publisher","first-page":"720952","DOI":"10.3389\/fimmu.2021.720952","volume":"12","author":"H Jacobsen","year":"2021","unstructured":"Jacobsen H, Klein SL. Sex differences in immunity to viral infections. Front Immunol. 2021;12:720952.","journal-title":"Front Immunol"},{"issue":"8","key":"3587_CR24","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/gut.2005.078147","volume":"55","author":"I Bakr","year":"2006","unstructured":"Bakr I, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006;55(8):1183\u20137.","journal-title":"Gut"},{"issue":"1","key":"3587_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.26639","volume":"59","author":"J Grebely","year":"2014","unstructured":"Grebely J, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014;59(1):109\u201320.","journal-title":"Hepatology"},{"issue":"1","key":"3587_CR26","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1038\/s41598-023-29262-z","volume":"13","author":"M Abdel-Gawad","year":"2023","unstructured":"Abdel-Gawad M, et al. Gender differences in prevalence of hepatitis C virus infection in Egypt: a systematic review and meta-analysis. Sci Rep. 2023;13(1):2499.","journal-title":"Sci Rep"},{"key":"3587_CR27","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3389\/fimmu.2018.02302","volume":"9","author":"A Ruggieri","year":"2018","unstructured":"Ruggieri A, Gagliardi MC, Anticoli S. Sex-dependent outcome of Hepatitis B and C viruses infections: Synergy of Sex hormones and Immune responses? Front Immunol. 2018;9:2302.","journal-title":"Front Immunol"},{"key":"3587_CR28","unstructured":"Sharma A et al. PLoS One."},{"issue":"2","key":"3587_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1046\/j.1440-1746.2002.02605.x","volume":"17","author":"V Thakur","year":"2002","unstructured":"Thakur V, et al. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol. 2002;17(2):165\u201370.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"3587_CR30","doi-asserted-by":"publisher","first-page":"a021436","DOI":"10.1101\/cshperspect.a021436","volume":"5","author":"CL Lin","year":"2015","unstructured":"Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med. 2015;5(5):a021436.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3587_CR31","doi-asserted-by":"crossref","unstructured":"Shen C et al. Hepat Virus Hepatocellular Carcinoma: Recent Adv 2023. 15(2).","DOI":"10.3390\/cancers15020533"},{"issue":"4","key":"3587_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jcv.2004.03.019","volume":"31","author":"S Raghuraman","year":"2004","unstructured":"Raghuraman S, et al. HCV genotype 4\u2013an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol. 2004;31(4):253\u20138.","journal-title":"J Clin Virol"},{"issue":"1","key":"3587_CR33","first-page":"313","volume":"8","author":"P Desikan","year":"2019","unstructured":"Desikan P, et al. Sero-occurrence of HBV\/HCV co-infection and levels of liver enzymes among patients at a Tertiary Care Hospital in Central India: a pilot study. Cent Asian J Glob Health. 2019;8(1):313.","journal-title":"Cent Asian J Glob Health"},{"issue":"2","key":"3587_CR34","first-page":"869","volume":"77","author":"S Khan","year":"2022","unstructured":"Khan S, et al. Comparison of biochemical parameters in patients with Hepatitis B, C, and dual Hepatitis B and C in Northwest Pakistan. Arch Razi Inst. 2022;77(2):869\u201379.","journal-title":"Arch Razi Inst"},{"key":"3587_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1743-422X-8-293","volume":"8","author":"W Ahmad","year":"2011","unstructured":"Ahmad W, et al. HCV genotype-specific correlation with serum markers: higher predictability for genotype 4a. Virol J. 2011;8:293.","journal-title":"Virol J"},{"key":"3587_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1743-422X-8-361","volume":"8","author":"B Ijaz","year":"2011","unstructured":"Ijaz B, et al. Association of laboratory parameters with viral factors in patients with hepatitis C. Virol J. 2011;8:361.","journal-title":"Virol J"},{"issue":"1","key":"3587_CR37","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1186\/s12885-019-6040-3","volume":"19","author":"HK Park","year":"2019","unstructured":"Park HK, et al. Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma. BMC Cancer. 2019;19(1):822.","journal-title":"BMC Cancer"},{"key":"3587_CR38","doi-asserted-by":"crossref","unstructured":"Hoan NX et al. Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis. 2021. 13(2).","DOI":"10.3390\/v13020346"},{"issue":"22","key":"3587_CR39","doi-asserted-by":"publisher","first-page":"10986","DOI":"10.1128\/JVI.01124-08","volume":"82","author":"AT Tan","year":"2008","unstructured":"Tan AT, et al. Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol. 2008;82(22):10986\u201397.","journal-title":"J Virol"},{"key":"3587_CR40","doi-asserted-by":"crossref","unstructured":"Dong Z, et al. Molecular epidemiology of hepatitis B virus genotypes and subgenotypes in ethnic minority populations, Yunnan province, China. Volume 150. Epidemiology & Infection; 2022. p. e11.","DOI":"10.1017\/S0950268821002326"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03587-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03587-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03587-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T22:02:40Z","timestamp":1736373760000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03587-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3587"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03587-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for the study was obtained from the Institutional Review Board of the National University of Science and Technology (NUST), Pakistan (IRB No. 01-2019-03\/06). Written and oral informed consent were attained from each participant before the collection of blood samples. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}